Aldevron is exhibiting at the CAR-TCR Summit in London February 25 – 27, 2019, and was excited to share the news of our partnership with Oxford Genetics to produce lentivirus. Click here to read the interview with James Brown, Aldevron’s Vice President of Corporate Development about the collaboration.
Aldevron, a global provider of plasmid DNA and gene editing enzymes used to support novel cancer therapies, will be a Platinum sponsor of the 2017 Believe Ball organized by the Emily Whitehead Foundation. In its inaugural year, the Believe Ball will bring together T-Cell therapy patients and their families with the doctors, scientists, researchers, and others who helped develop this therapy.
Aldevron licenses minicircle technology to support collaboration with Myeloma Crowd and the development of multiple myeloma treatments
Aldevron to produce minicircles to support cell therapy applications
Aldevron, along with the Myeloma Crowd, a non-profit foundation dedicated to multiple myeloma patient education, advocacy and research funding, will collaborate to support research toward the advancement of treatments and a cure for multiple myeloma.